Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214970
Company: MEDEFIL INC
Company: MEDEFIL INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/04/2022 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
ATROPINE SULFATE
SOLUTION;INTRAVENOUS; 1MG/10ML (0.1MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 212868 | ACCORD HLTHCARE |
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 215342 | AMNEAL |
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | Yes | AP | 021146 | HOSPIRA |
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 212461 | INTL MEDICATION SYS |
ATROPINE SULFATE | ATROPINE SULFATE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 214970 | MEDEFIL INC |